ARCHIVES

Celgene Signs CRADA With NCI For Development Of CDC-501.

This article is from The Cancer Letter archive.

Vol. 26 No. 26 | June 30, 2000

Download PDF Visit The Full Archive

Related Articles

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

April 29, 2011

In Brief: Disapproved CCP Wins Appeal; New Review; Trish Greene Named ACS VP For Nursing

February 26, 1988

M.D. Anderson Must Evaluate 8 Patients In Controversial Study

May 31, 1996

NCI Agrees To give NSABP One Year Until Competition; Advisors OK Concept

June 17, 1994

FDA Places Controls On Silicone Implants, Though Still Available For Reconstruction

April 25, 1992

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014